Basel stent cost-effectiveness trial-late thrombotic events trial

被引：4
|
作者：
Richartz, B
Silber, S
机构：
来源：
HERZ | 2006年 / 31卷 / 03期
关键词：
D O I：
10.1007/s00059-006-2828-4
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：259 / 259
页数：1
相关论文
共 50 条
  • [1] Die BASKET-LATE-StudieBasel Stent Cost-Effectiveness Trial-Late Thrombotic Events Trial
    Herz Kardiovaskuläre Erkrankungen, 2006, 31 : 259 - 259
  • [2] Basel Stent cost-effectiveness trial (Basel Stent Kosten Effektivitats Trials; BASKET): trial design and comparison of baseline findings with those of the RESEARCH trial
    Kaiser, C.
    Bernheim, A.
    Zutter, A.
    Brunner-La-Rocca, H. P.
    Buser, P.
    Osswald, S.
    Linka, A.
    Pfisterer, M.
    EUROPEAN HEART JOURNAL, 2005, 26 : 708 - 708
  • [3] Do drug-eluting stents reduce in-hospital events compared to bare metal stents? First results of the prospective Basel stent cost-effectiveness trial (Basel Stent Kosten Effektivitaets Trial)
    Kaiser, C.
    Brunner-La Rocca, H. P.
    Zutter, A.
    Bernheim, A.
    Osswald, S.
    Buser, P.
    Linka, A.
    Pfisterer, M.
    EUROPEAN HEART JOURNAL, 2005, 26 : 313 - 313
  • [4] Targeted stent use in clinical practice based on evidence from the Basel Stent Cost Effectiveness Trial (BASKET)
    Agostoni, Pierfrancesco
    Vermeersch, Paul
    Verheye, Stefan
    Van den Heuvel, Paul
    Carl, Convens
    Van den Branden, Frank
    Van Langenhove, Glenn
    EUROPEAN HEART JOURNAL, 2007, 28 (15) : 1912 - 1913
  • [5] Targeted stent use in clinical practice based on evidence from the BAsel Stent Cost Effectiveness Trial (BASKET)
    Brunner-La Rocca, Hans-Peter
    Kaiser, Christoph
    Pfisterer, Matthias
    EUROPEAN HEART JOURNAL, 2007, 28 (06) : 719 - 725
  • [6] Targeted stent use in clinical practice based on evidence from the Basel Stent Cost Effectiveness Trial (BASKET): Reply
    Pfisterer, Matthias
    Kaiser, Christoph
    Brunner-La-Rocca, Hanspeter
    EUROPEAN HEART JOURNAL, 2007, 28 (15) : 1913 - 1913
  • [7] Cost-effectiveness of drug-eluting stents in patients at high or low risk of major cardiac events in the Basel Stent KostenEffektivitats Trial (BASKET): an 18-month analysis
    Brunner-La Rocca, Hans Peter
    Kaiser, Christoph
    Bernheim, Alain
    Zellweger, Michael J.
    Jeger, Raban
    Buser, Peter T.
    Osswald, Stefan
    Pfisterer, Matthias
    LANCET, 2007, 370 (9598): : 1552 - 1559
  • [8] Cost-effectiveness of the Hall Technique in a Randomized Trial
    Schwendicke, F.
    Krois, J.
    Robertson, M.
    Splieth, C.
    Santamaria, R.
    Innes, N.
    JOURNAL OF DENTAL RESEARCH, 2019, 98 (01) : 61 - 67
  • [9] LOVASTATIN IN PRAVASTATIN COMPARATIVE TRIAL - COST-EFFECTIVENESS
    FARBSTEIN, S
    AMERICAN JOURNAL OF CARDIOLOGY, 1994, 73 (05): : 417 - 417
  • [10] Approach to cost-effectiveness assessment in the MADIT trial
    Mushlin, AI
    Zwanziger, J
    Gajary, E
    Andrews, M
    Marron, R
    AMERICAN JOURNAL OF CARDIOLOGY, 1997, 80 : F33 - F41
12345